Valuation: Maravai LifeSciences Holdings, Inc.

Market Cap 996M 866M 806M 740M 1.4B 95.05B 1.42B 9.5B 3.73B 47.32B 3.74B 3.66B 159B P/E 2026 *
-21.8x
P/E 2027 * -29x
Enterprise Value 1.01B 877M 817M 750M 1.42B 96.33B 1.44B 9.62B 3.78B 47.96B 3.79B 3.71B 161B EV / Sales 2026 *
4.8x
EV / Sales 2027 * 4.26x
Free-Float
41.44%
Yield 2026 *
-
Yield 2027 * -
1 day-2.67%
1 week-6.81%
Current month+5.29%
1 month+5.29%
3 months+78.53%
6 months+95.54%
Current year+102.15%
1 week 6.45
Extreme 6.45
7.02
1 month 5.67
Extreme 5.67
7.44
Current year 2.8
Extreme 2.8
7.44
1 year 1.99
Extreme 1.99
7.44
3 years 1.66
Extreme 1.665
12.1
5 years 1.66
Extreme 1.665
63.55
10 years 1.66
Extreme 1.665
63.55
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-07
Director of Finance/CFO 59 2025-06-29
Chief Operating Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 50 2016-02-29
Director/Board Member 65 2020-10-31
Director/Board Member 61 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
7/8/26 Tax

Chief Executive Officer

-29,250 0.0198%
6/30/26 Tax

Chief Financial Officer

-65,584 0.0445%
6/8/26 Tax

Chief Executive Officer

-351,001 0.2380%
Change 5-day change 1-year change 3-year change Capi.($)
-2.67%-6.81%+172.61%-42.62% 996M
-22.52%-19.97%+93.24%+64.84% 4.77B
-6.66%+1.17%+116.19%+179.68% 3.85B
+3.44%+3.61%-27.51%-36.11% 2.09B
-13.22%-20.66%+52.43%-43.47% 2.09B
+14.72%+16.22%+239.89%+291.67% 1.97B
+6.96%-2.36%-9.88%+25.41% 802M
+1.29%+2.60%-37.77%-13.45% 504M
+7.90%+0.67%+1.90% - 419M
+1.09%-6.25%+72.22%+8.64% 149M
Average -0.80%-4.42%+67.33%+48.29% 1.76B
Weighted average by Cap. -6.46%-3.15%+89.13%+80.14%

Financials

2026 *2027 *
Net sales 210M 183M 170M 156M 295M 20.09B 300M 2.01B 788M 10B 790M 773M 33.53B 226M 196M 183M 168M 317M 21.56B 322M 2.15B 845M 10.73B 848M 830M 35.99B
Net income -39.2M -34.07M -31.71M -29.12M -54.99M -3.74B -55.84M -374M -147M -1.86B -147M -144M -6.25B -28.2M -24.51M -22.82M -20.95M -39.56M -2.69B -40.17M -269M -106M -1.34B -106M -104M -4.49B
Net Debt 13.46M 11.7M 10.89M 10M 18.88M 1.28B 19.17M 128M 50.37M 640M 50.54M 49.43M 2.14B -33.46M -29.09M -27.08M -24.86M -46.95M -3.19B -47.67M -319M -125M -1.59B -126M -123M -5.33B
Logo Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.
Employees
416
Date Price Change Volume
26-07-31 US$6.570 -2.67% 1,087,352
26-07-30 US$6.750 +2.43% 1,251,381
26-07-29 US$6.590 -3.94% 1,931,709
26-07-28 US$6.860 +2.54% 2,412,772
26-07-27 US$6.690 -1.04% 2,195,143
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
6.750USD
Average target price
5.900USD
Spread / Average Target
-12.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MRVI Stock